All In Biotech

Drug Trial Radar · NCT03962543

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity

Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

114

Actual

Start

Sep 29, 2019

Primary completion

Sep 20, 2023

Study completion Dec 22, 2028

Sponsor

Sponsor type
Industry
First posted
May 24, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates mirdametinib (PD-0325901) in the treatment of symptomatic inoperable neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas (PNs). All participants will receive mirdametinib (PD-0325901). Eligible participants may continue in a long-term follow-up phase.

Conditions

  • Plexiform Neurofibroma
  • Neurofibromatosis Type 1 (NF1)

Interventions

  • Mirdametinib (PD-0325901) oral capsule or dispersible tabletDrug

    Mirdametinib (PD-0325901) capsule or dispersible tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Confirmed Objective Response Rate at the End of the Treatment Phase.Time frame: Up to 24 months

Locations

43 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham (UAB) - Children's of Alabama

    Birmingham, Alabama

  • Mayo Clinic Arizona

    Phoenix, Arizona

  • Arkansas Children's Hospital - University of Arkansas

    Little Rock, Arkansas

  • Children's Hospital Los Angeles

    Los Angeles, California

  • University of California, Los Angeles (UCLA)

    Los Angeles, California

  • Children's Hospital of Orange County

    Orange, California

  • University of California - Irvine Health

    Orange, California

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California

  • University of California - Davis

    Sacramento, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Nemours A. I. duPont Hospital for Children

    Wilmington, Delaware

  • Children's National Hospital

    Washington D.C., District of Columbia

  • University of Florida (UF) - Gainesville

    Gainesville, Florida

  • Nicklaus Children's Hospital

    Miami, Florida

  • Florida Hospital Cancer Institute

    Orlando, Florida

  • Arnold Palmer Hospital for Children

    Orlando, Florida

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida

  • Moffitt

    Tampa, Florida

  • University of Illinois Hospital

    Chicago, Illinois

  • Indiana University

    Indianapolis, Indiana

  • University of Iowa Health Care

    Iowa City, Iowa

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • University of Minnesota Masonic Cancer Center

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University

    St Louis, Missouri

  • Saint Joseph's Regional Medical Center

    Paterson, New Jersey

  • Albany Medical Center

    Albany, New York

  • Children's Hospital at Montefiore

    The Bronx, New York

  • University of North Carolina (UNC) Hospitals

    Chapel Hill, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • UC Health

    Cincinnati, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • University of Oklahoma - Health Sciences Center

    Oklahoma City, Oklahoma

  • Oregon Health and Science University

    Portland, Oregon

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • Vanderbilt Children's Hospital

    Nashville, Tennessee

  • University of Texas Southwestern

    Dallas, Texas

  • Cook Children's Medical Center

    Fort Worth, Texas

  • MD Anderson Cancer Center

    Houston, Texas

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.